Cargando…

Comparison of the Long-Term Remission of Rituximab and Conventional Treatment for Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Review and Meta-Analysis

The current systematic review and meta-analysis aimed to summarize the results of all available studies to compare the efficacies of rituximab and conventional treatment for acquired thrombotic thrombocytopenic purpura (TTP). Three investigators independently searched studies in the MEDLINE and EMBA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owattanapanich, Weerapat, Wongprasert, Chompunut, Rotchanapanya, Wannaphorn, Owattanapanich, Natthida, Ruchutrakool, Theera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714958/ https://www.ncbi.nlm.nih.gov/pubmed/30808221 http://dx.doi.org/10.1177/1076029618825309

Ejemplares similares

Prevention of High-Dose Cytosine Arabinoside-Induced Acute Pericarditis with Preemptive Dexamethasone Administration: A Case Report and Literature Review
por: Owattanapanich, Weerapat, et al.
Publicado: (2018)

Clinical Outcomes Based on Measurable Residual Disease Status in Patients with Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
por: Rotchanapanya, Wannaphorn, et al.
Publicado: (2020)

High Incidence of Antiphospholipid Antibodies in Newly Diagnosed Patients With Lymphoma and a Proposed aPL Predictive Score
por: Kungwankiattichai, Smith, et al.
Publicado: (2020)

Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis
por: Rungjirajittranon, Tarinee, et al.
Publicado: (2021)

A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
por: Rungjirajittranon, Tarinee, et al.
Publicado: (2019)

Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis
por: Rungjirajittranon, Tarinee, et al.
Publicado: (2022)

Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients
por: Owattanapanich, Weerapat, et al.
Publicado: (2023)

Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
por: Chen, Haifei, et al.
Publicado: (2017)

Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis
por: Rungjirajittranon, Tarinee, et al.
Publicado: (2022)

A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report
por: Rungjirajittranon, Tarinee, et al.
Publicado: (2019)

Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012)

A Novel Case of Cytomegalovirus Pneumonia in an Acquired Thrombotic Thrombocytopenic Purpura Patient Treated With Rituximab
por: Kandah, Emad, et al.
Publicado: (2021)

Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura
por: Little, Dustin J., et al.
Publicado: (2017)

Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome—excess blasts detected by next-generation sequencing technique
por: Owattanapanich, Weerapat, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)

Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura
por: Hanlon, Ashley, et al.
Publicado: (2020)

Tozinameran: Acquired thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

Acquired Thrombotic Thrombocytopenic Purpura in a Patient with Pernicious Anemia
por: Pandey, Ramesh Kumar, et al.
Publicado: (2017)

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
por: Elverdi, Tugrul, et al.
Publicado: (2019)

Tozinameran: Acquired thrombotic thrombocytopenic purpura: 4 case reports
Publicado: (2021)

AZD-1222: Acquired thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura: A case report
por: Chaurasiya, Prem Shankar, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

Dengue and Thrombotic Thrombocytopenic Purpura
por: Wiwanitkit, Viroj
Publicado: (2017)

Vaccination and Thrombotic Thrombocytopenic Purpura
por: Yavaşoğlu, İrfan
Publicado: (2020)

Caplacizumab for thrombotic thrombocytopenic purpura
Publicado: (2020)

Hereditary Thrombotic Thrombocytopenic Purpura
por: Nusrat, Sanober, et al.
Publicado: (2023)

Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion—rapid remission following complement blockade
por: Bitzan, Martin, et al.
Publicado: (2018)

P2Y12 inhibition after thrombotic thrombocytopenic purpura remission
por: Kahraman, Serkan, et al.
Publicado: (2017)

Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
por: Bichard, Christian, et al.
Publicado: (2022)

Efficacy of local tranexamic acid treatment for prevention of bleeding after dental procedures: A systematic review and meta-analysis
por: Owattanapanich, Duangrat, et al.
Publicado: (2019)

P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)
por: Marín Sánchez, E., et al.
Publicado: (2022)

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura()
por: Thomas, Mari R., et al.
Publicado: (2015)

Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19
por: Capecchi, Marco, et al.
Publicado: (2020)

Clinical Efficacy and Safety Profile of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2019)

The Long and Winding Road for New Treatments for Acquired Thrombotic Thrombocytopenic Purpura
por: Schutgens, Roger E.G.
Publicado: (2019)

Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
por: Alislambouli, Mawaddah, et al.
Publicado: (2021)

Rituximab Prevents Stroke Recurrences in Atypical Chronic Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Dupuy, Henry, et al.
Publicado: (2018)

Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab
por: Falter, Tanja, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_965nvfqmm589ka12nmapucuu1t